P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials-Reference-Cited by-同舟云学术

P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials

Published:2020-09 Issue: Volume:227 Page:82-90
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kuno Toshiki,Ueyama Hiroki,Takagi Hisato,Bangalore Sripal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

2. Antithrombotic therapy after percutaneous coronary intervention from the Japanese perspective;Saito;Cardiovasc Interv Ther,2020

3. Meta-analysis for impact of statin on mortality after transcatheter aortic valve implantation;Takagi;Am J Cardiol,2019

4. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration;Liberati;Ann Intern Med,2009

5. Network meta-analysis using R: a review of currently available automated packages;Neupane;PloS one,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of the Ticagrelor Trials Evidence Base;Journal of the American Heart Association;2024-06-04

2. Preferred monotherapy after short-term dual antiplatelet therapy: Systematic review and network meta-analysis of randomized trials;Journal of Cardiology;2023-08

3. Long-term Management of Patients with Myocardial Infarction: An Updated Review;Cardiology Discovery;2022-11-01

4. Clopidogrel Monotherapy versus Aspirin Monotherapy in Patients with Established Cardiovascular Disease: Systematic Review and Meta-Analysis;Thrombosis and Haemostasis;2022-05-16

5. Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes;American Heart Journal;2022-04